Literature DB >> 31852785

Ebola Virus Produces Discrete Small Noncoding RNAs Independently of the Host MicroRNA Pathway Which Lack RNA Interference Activity in Bat and Human Cells.

Abhishek N Prasad1,2,3, Adam J Ronk1,2,3, Steven G Widen4, Thomas G Wood4, Christopher F Basler5, Alexander Bukreyev6,7,2,3.   

Abstract

The question as to whether RNA viruses produce bona fide microRNAs (miRNAs) during infection has been the focus of intense research and debate. Recently, several groups using computational prediction methods have independently reported possible miRNA candidates produced by Ebola virus (EBOV). Additionally, efforts to detect these predicted RNA products in samples from infected animals and humans have produced positive results. However, these studies and their conclusions are predicated on the assumption that these RNA products are actually processed through, and function within, the miRNA pathway. In the present study, we performed the first rigorous assessment of the ability of filoviruses to produce miRNA products during infection of both human and bat cells. Using next-generation sequencing, we detected several candidate miRNAs from both EBOV and the closely related Marburg virus (MARV). Focusing our validation efforts on EBOV, we found evidence contrary to the idea that these small RNA products function as miRNAs. The results of our study are important because they highlight the potential pitfalls of relying on computational methods alone for virus miRNA discovery.IMPORTANCE Here, we report the discovery, via deep sequencing, of numerous noncoding RNAs (ncRNAs) derived from both EBOV and MARV during infection of both bat and human cell lines. In addition to identifying several novel ncRNAs from both viruses, we identified two EBOV ncRNAs in our sequencing data that were near-matches to computationally predicted viral miRNAs reported in the literature. Using molecular and immunological techniques, we assessed the potential of EBOV ncRNAs to function as viral miRNAs. Importantly, we found little evidence supporting this hypothesis. Our work is significant because it represents the first rigorous assessment of the potential for EBOV to encode viral miRNAs and provides evidence contrary to the existing paradigm regarding the biological role of computationally predicted EBOV ncRNAs. Moreover, our work highlights further avenues of research regarding the nature and function of EBOV ncRNAs.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Ebola virus; Marburg virus; RNA interference; bats; deep sequencing; filoviruses; microRNA; noncoding RNA

Mesh:

Substances:

Year:  2020        PMID: 31852785      PMCID: PMC7158719          DOI: 10.1128/JVI.01441-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  123 in total

1.  Primers with 5' flaps improve real-time PCR.

Authors:  Irina Afonina; Irina Ankoudinova; Alan Mills; Sergey Lokhov; Phan Huynh; Walt Mahoney
Journal:  Biotechniques       Date:  2007-12       Impact factor: 1.993

2.  Identification of Ebola virus microRNAs and their putative pathological function.

Authors:  HongWei Liang; Zhen Zhou; SuYang Zhang; Ke Zen; Xi Chen; ChenYu Zhang
Journal:  Sci China Life Sci       Date:  2014-09-29       Impact factor: 6.038

3.  Reply to 'Questioning antiviral RNAi in mammals'.

Authors:  Kate L Jeffrey; Yang Li; Shou-Wei Ding
Journal:  Nat Microbiol       Date:  2017-04-25       Impact factor: 17.745

4.  Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase.

Authors:  Michel Liuzzi; Stephen W Mason; Mireille Cartier; Carol Lawetz; Robert S McCollum; Nathalie Dansereau; Gordon Bolger; Nicole Lapeyre; Yvon Gaudette; Lisette Lagacé; Marie-Josée Massariol; Florence Dô; Paul Whitehead; Lyne Lamarre; Erika Scouten; Josée Bordeleau; Serge Landry; Jean Rancourt; Gulrez Fazal; Bruno Simoneau
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

5.  Characterization of the RNA silencing suppression activity of the Ebola virus VP35 protein in plants and mammalian cells.

Authors:  Yali Zhu; Nil Celebi Cherukuri; Jamie N Jackel; Zetang Wu; Monica Crary; Kenneth J Buckley; David M Bisaro; Deborah S Parris
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

6.  Establishment of fruit bat cells (Rousettus aegyptiacus) as a model system for the investigation of filoviral infection.

Authors:  Verena Krähling; Olga Dolnik; Larissa Kolesnikova; Jonas Schmidt-Chanasit; Ingo Jordan; Volker Sandig; Stephan Günther; Stephan Becker
Journal:  PLoS Negl Trop Dis       Date:  2010-08-24

7.  Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA.

Authors:  Demián Cazalla; Therese Yario; Joan A Steitz; Joan Steitz
Journal:  Science       Date:  2010-06-18       Impact factor: 47.728

8.  Influenza A virus expresses high levels of an unusual class of small viral leader RNAs in infected cells.

Authors:  Jennifer L Umbach; Hui-Ling Yen; Leo L M Poon; Bryan R Cullen
Journal:  MBio       Date:  2010-09-14       Impact factor: 7.867

9.  RNA virus building blocks-miRNAs not included.

Authors:  Lauren C Aguado; Benjamin tenOever
Journal:  PLoS Pathog       Date:  2018-05-31       Impact factor: 6.823

10.  The rough endoplasmatic reticulum is a central nucleation site of siRNA-mediated RNA silencing.

Authors:  Lukas Stalder; Wolf Heusermann; Lena Sokol; Dominic Trojer; Joel Wirz; Justin Hean; Anja Fritzsche; Florian Aeschimann; Vera Pfanzagl; Pascal Basselet; Jan Weiler; Martin Hintersteiner; David V Morrissey; Nicole C Meisner-Kober
Journal:  EMBO J       Date:  2013-03-19       Impact factor: 11.598

View more
  3 in total

1.  Ebola Virus Encodes Two microRNAs in Huh7-Infected Cells.

Authors:  Idrissa Diallo; Zeinab Husseini; Sara Guellal; Elodie Vion; Jeffrey Ho; Robert A Kozak; Gary P Kobinger; Patrick Provost
Journal:  Int J Mol Sci       Date:  2022-05-07       Impact factor: 6.208

Review 2.  RNA Virus-Encoded miRNAs: Current Insights and Future Challenges.

Authors:  Asuka Nanbo; Wakako Furuyama; Zhen Lin
Journal:  Front Microbiol       Date:  2021-06-24       Impact factor: 5.640

Review 3.  Artificial Light at Night (ALAN): A Potential Anthropogenic Component for the COVID-19 and HCoVs Outbreak.

Authors:  Zeeshan Ahmad Khan; Thangal Yumnamcha; Gopinath Mondal; Sijagurumayum Dharmajyoti Devi; Chongtham Rajiv; Rajendra Kumar Labala; Haobijam Sanjita Devi; Asamanja Chattoraj
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-10       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.